Showing results (271-280 of 632) with videos related to
Sort By:
Pageof 64
American Journal of Respiratory Cell and Molecular Biology|March 1, 1991
Substance P and neurokinin A in human nasal mucosaJ N Baraniuk, J D Lundgren, M Okayama, et al.Controlled Clinical Trials|April 12, 2002
The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRITSean Emery, Donald I Abrams, David A Cooper, et al.Comprehensive Psychiatry|January 25, 2014
Validation of screening questions and symptom coherence of night eating in the Swedish Twin RegistryKelly C Allison, Jennifer D Lundgren, Albert J Stunkard, et al.The Journal of Infectious Diseases|June 28, 2025
The gut microbiome and its resistome as predictors of clinical infections and phenotypic antibiotic resistance in hematopoietic stem cell transplant recipientsJens C Nørgaard, Ramtin Z Marandi, Emma Elizabeth Ilett, et al.Biorxiv : the Preprint Server for Biology|February 23, 2026
External validation and time-stability analysis of STARE, a blood-free quantification tool for irreversible PET tracersGjertrud L Laurell, Elizabeth A Bartlett, Mike Schmidt, et al.The American Review of Respiratory Disease|March 1, 1990
Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivoJ N Baraniuk, J D Lundgren, H Mizoguchi, et al.Frontiers in Immunology|October 5, 2020
Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal LeishmaniasisCamilla Heldbjerg Drabe, Rasmus L Marvig, Line Borgwardt, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) TrialJeffrey A Boatman, Jason V Baker, Sean Emery, et al.The Journal of Infectious Diseases|December 16, 2017
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) StudyAndreas Ronit, Shweta Sharma, Jason V Baker, et al.Respiratory Medicine|August 28, 1999
Pneumocystis carinii pneumonia in HIV-infected patients: effect of steroid therapy on surfactant levelJ R Dichter, J D Lundgren, T L Nielsen, et al.Pageof 64